STANDARD THERAPY VERSUS AUTOLOGOUS TRANSPLANTATION IN MULTIPLE MYELOMA
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 11 (1), 133-146
- https://doi.org/10.1016/s0889-8588(05)70419-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Limited value of myeloablative therapy for late multiple myelomaBlood, 1994
- Monoclonal antibody-purged bone marrow transplantation therapy for multiple myelomaBlood, 1993
- Plasma cell dyscrasiasPublished by American Medical Association (AMA) ,1992
- Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patientsBlood, 1992
- Intensive combined therapy for previously untreated aggressive myelomaBlood, 1992
- Prognostic factors with high-dose melphalan for refractory multiple myeloma [see comments]Blood, 1988
- High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myelomaBlood, 1987
- High-dose melphalan with autologous bone marrow transplantation for multiple myelomaBlood, 1986
- Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimensJAMA, 1969